Summary Report: Involving and Engaging People with Cancer in Oncology Drug Development
The CDDF is delighted to announce that the summary report, Involving and Engaging People with Cancer in Oncology Drug Development, has been published today. This report is prepared by Professor Mark Lawler (Queen’s University Belfast & Board of the CDDF) and...
Multi-Stakeholder Interviews: CDDF Workshop on Dose Optimization in Early Oncology Drug Development (3-4 April 2023, NL)
[WATCH THE CDDF’S INTERVIEWS WITH MULTI-STAKEHOLDERS IN ONCOLOGY] The CDDF multi-stakeholder workshop on Dose Optimization in Early Oncology Drug Development (3-4 April 2023, Amsterdam) generated lots of interest and fruitful discussion among meeting attendees from...![[New Publication]: Meeting Report of the Annual Conference 2023](https://cddf.org/wp-content/uploads/2023/04/EXECUTIVE-SUMMARY-1-1080x675.jpg)
[New Publication]: Meeting Report of the Annual Conference 2023
📢 The Cancer Drug Development Forum (CDDF) is happy to inform all stakeholders that its meeting report of the Annual Conference 2023 has been published. The 2023 edition of the multi-stakeholder conference took place on 6-8 February 2023 in Noordwijk aan zee, NL. It...
Executive Summary of the Workshop on “Dose Optimization in Early Oncology Drug Development” (April 2023, Amsterdam)
The Cancer Drug Development Forum (CDDF) has published its executive summary of the workshop on “Dose Optimization in Early Oncology Drug Development.” The multi-stakeholder workshop took place on 3-4 April 2023 in Amsterdam, NL. The gathering brought together the...